Patent · US Active

Treatment of cancer, inflammatory disease, and autoimmune disease

US9359279B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2014
Grant dateJun 7, 2016
Priority date
Expiry dateAug 28, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A method of treating cancer, inflammatory disease, and autoimmune disease by administering to a subject in need thereof an effective amount of one or more 1,5-dipenylpenta-1,4-dien-3-one compounds. The compounds feature either or both of the phenyl rings being substituted with hydroxyl, diethyl(2-alkoxyethyl)amine, 1-(2-alkoxyethyl)piperidine, sulfonate, phosphinate, or phosphate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.